SANCISI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 518
EU - Europa 141
AS - Asia 114
AF - Africa 1
Totale 774
Nazione #
US - Stati Uniti d'America 515
SG - Singapore 52
IT - Italia 37
CN - Cina 35
GB - Regno Unito 33
DE - Germania 17
FI - Finlandia 13
HK - Hong Kong 11
SE - Svezia 11
RU - Federazione Russa 9
UA - Ucraina 9
ID - Indonesia 7
TR - Turchia 5
BG - Bulgaria 3
LT - Lituania 3
CA - Canada 2
IE - Irlanda 2
IN - India 2
NL - Olanda 2
BZ - Belize 1
CZ - Repubblica Ceca 1
EG - Egitto 1
FR - Francia 1
IR - Iran 1
JP - Giappone 1
Totale 774
Città #
Santa Clara 159
Fairfield 55
Ashburn 46
Singapore 46
Woodbridge 32
Southend 28
Seattle 27
Wilmington 22
Cambridge 21
Houston 20
Chandler 17
Ann Arbor 16
Jacksonville 16
Helsinki 11
Hong Kong 11
Nyköping 11
Parma 8
Beijing 7
Jakarta 7
Munich 7
Dearborn 6
Modena 6
Moscow 6
Princeton 6
Los Angeles 5
New York 4
Boardman 3
Chieti 3
Duncan 3
Eugene 3
San Diego 3
Shanghai 3
Sofia 3
Amsterdam 2
Dublin 2
Francavilla al Mare 2
Kilburn 2
Rome 2
San Benedetto del Tronto 2
San Mateo 2
Ardabil 1
Belize City 1
Bremen 1
Cairo 1
Cheyenne 1
Chongqing 1
Ferrara 1
Fornovo di Taro 1
Hangzhou 1
Hounslow 1
Indiana 1
Izmir 1
Kunming 1
Milan 1
Nagpur 1
Nanjing 1
New Bedfont 1
Olomouc 1
Ottawa 1
Prescot 1
Reggio Emilia 1
San Giuliano Milanese 1
Shenyang 1
Suzuka 1
Toronto 1
Totale 660
Nome #
Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1). 184
A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases 161
The extent of whole-genome copy number alterations predicts aggressive features in primary melanomas 153
KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM) 60
RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN 36
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas 34
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer: insights into mitochondrial modulation 28
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 28
Dissecting the role of lncRNAs in promoting Natural Killer cytotoxicity in Non-Small Cell Lung Cancer models 27
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 23
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 22
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 20
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 20
Totale 796
Categoria #
all - tutte 4.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202092 0 0 0 0 0 19 20 16 19 4 11 3
2020/202192 10 7 6 9 10 4 5 17 2 13 7 2
2021/202245 4 5 0 0 0 4 3 2 10 3 11 3
2022/202363 6 4 5 4 9 9 6 4 5 5 2 4
2023/202480 5 2 9 10 8 6 9 6 2 0 6 17
2024/2025291 6 24 27 39 113 82 0 0 0 0 0 0
Totale 796